Objectives: To assess the efficiency in terms of cost-effectiveness (CE) of oral Renalof？ treatment versus extracorporeal shockwave lithotripsy (ESWL) in the treatment of kidney stones ≤ 1 cm in Nicaragua. Methods: A cost-effectiveness economic evaluation was carried out based on the results obtained in the randomised, prospective, observational, single-blind, prospective, phase 2 clinical trial. Cost-effectiveness and the incremental cost-effectiveness ratio (ICER) were calculated. Economic data were obtained from the Economics Department of Clínica Senior in Managua, Nicaragua. The monetary cost was expressed in US dollars (USD). Results: Treatment with Renalof？ yielded a CE of $1,323.08/% remission, while ESWL was $9,498.54/% remission. The ICER shows that, in order to achieve a high percentage of kidney stone remission with ESWL, an extra $4,734.70 per patient must be invested. Conclusions: The use of Renalof？ is shown to be a more cost-effective option than ESWL. It is recommended for the treatment of kidney stones ≤ 1 cm in size.
References
[1]
Chamorro, M.M.A., Collado, S.A.V. and Márquez, D. (2021) Effectiveness of Using Renalof® in the Elimination of Kidney Stones under 10 Mm Located in the Renal-Ureteral Tract. Open Journal of Nephrology, 11, 78-92. https://doi.org/10.4236/ojneph.2021.111007
[2]
Li, J., Zhao, Y., Xiong, Z. and Yang, G. (2023) Global, Regional, and National Incidence and Disability-Adjusted Life-Years for Urolithiasis in 195 Countries and Territories, 1990-2019: Results from the Global Burden of Disease Study 2019. Journal of Clinical Medicine, 12, Article No. 1048. https://doi.org/10.3390/jcm12031048
[3]
Borumandnia, N., Fattahi, P., Talebi, A., Taheri, M., Alvani, M.S., Balani, M.M., et al. (2023) Longitudinal Trend of Urolithiasis Incidence Rates among World Countries during Past Decades. BMC Urology, 23, Article No. 166. https://doi.org/10.1186/s12894-023-01336-0
[4]
Sorokin, I., Mamoulakis, C., Miyazawa, K., Rodgers, A., Talati, J. and Lotan, Y. (2017) Epidemiology of Stone Disease across the World. World Journal of Urology, 35, 1301-1320. https://doi.org/10.1007/s00345-017-2008-6
[5]
García-Perdomo, H.A., Solarte, P.B. and España, P.P. (2016) Pathophysiology Associated with Forming Urinary Stones. Urología Colombiana, 25, 118-125. https://doi.org/10.1016/j.uroco.2015.12.013
[6]
Sharma, A. and Filler, G. (2010) Epidemiology of Pediatric Urolithiasis. Indian Journal of Urology, 26, 516. https://doi.org/10.4103/0970-1591.74450
Aggarwal, R., Srivastava, A., Jain, S.K., Sud, R. and Singh, R. (2017) Renal Stones: A Clinical Review. EMJ Urology, 5, 98-103. https://doi.org/10.33590/emjurol/10310556
[9]
García, P.M., Luis, M.I. and García, V. (2023) Litiasis Renal. https://nefrologiaaldia.org/es-articulo-litiasis-renal-242
[10]
Setthawong, V., Srisubat, A., Potisat, S., Lojanapiwat, B. and Pattanittum, P. (2023) Extracorporeal Shock Wave Lithotripsy (ESWL) versus Percutaneous Nephrolithotomy (PCNL) or Retrograde Intrarenal Surgery (RIRS) for Kidney Stones. Cochrane Database of Systematic Reviews, 2023, CD007044. https://doi.org/10.1002/14651858.cd007044.pub4
[11]
Grosso, A.A., Sessa, F., Campi, R., Viola, L., Polverino, P., Crisci, A., et al. (2021) Intraoperative and Postoperative Surgical Complications after Ureteroscopy, Retrograde Intrarenal Surgery, and Percutaneous Nephrolithotomy: A Systematic Review. Minerva Urology and Nephrology, 73, 309-332. https://doi.org/10.23736/s2724-6051.21.04294-4
[12]
Jansen, J.P., Brewer, I.P., Chung, S., Sullivan, P., Espinosa, O.D. and Grossman, J.P. (2024) The Health Inequality Impact of a New Cancer Therapy Given Treatment and Disease Characteristics. Value in Health, 27, 143-152. https://doi.org/10.1016/j.jval.2023.11.001
[13]
Alić, J., Heljić, J., Hadžiosmanović, O., Kulovac, B., Lepara, Z., Spahović, H., et al. (2022) The Efficiency of Extracorporeal Shock Wave Lithotripsy (ESWL) in the Treatment of Distal Ureteral Stones: An Unjustly Forgotten Option? Cureus, 14, e28671. https://doi.org/10.7759/cureus.28671
[14]
Lessa, F., Caccavo, F., Curtis, S., Ouimet-Rathé, S. and Lemgruber, A. (2017) Strengthening and Implementing Health Technology Assessment and the Decision-Making Process in the Region of the Americas. Revista Panamericana de Salud Pública, 41, e165. https://doi.org/10.26633/rpsp.2017.165
[15]
Marseille, E., Larson, B., Kazi, D.S., Kahn, J.G. and Rosen, S. (2014) Thresholds for the Cost-Effectiveness of Interventions: Alternative Approaches. Bulletin of the World Health Organization, 93, 118-124. https://doi.org/10.2471/blt.14.138206
[16]
Bertram, M.Y. and Edejer, T.T.T. (2021) Introduction to the Special Issue on “the World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update”. International Journal of Health Policy and Management, 10, 670-672. https://doi.org/10.34172/ijhpm.2021.105
[17]
World Bank Open Data (2023). https://datos.bancomundial.org/indicator/NY.GDP.PCAP.CD?locations=NI
[18]
Soto, J. (2012) Cap. 1. Evaluación económica de medicamentos y tecnologías sanitarias. In: Fundamento e introducción a la evaluación económica de medicamentos y tecnologías sanitarias, Springer SBM Spain, 9-20.
[19]
Briggs, A., Claxton, K. and Sculpher, M. (2011) Decision Modelling for Health Economic Evaluation. Oxford University Press.
[20]
Consejo de Salubridad General (2017) Guía para la conducción de estudios de evaluación económica para la actualización del cuadro básico y catálogo de insumos del sector salud en México. https://www.csg.gob.mx/descargas/pdf/priorizacion/cuadro-basico/guias/conduccion_estudios/GCEEE_2017_Diciembre_x1x.pdf
[21]
Aiumtrakul, N., Thongprayoon, C., Suppadungsuk, S., Krisanapan, P., Pinthusopon, P., Mao, M.A., et al. (2024) Global Trends in Kidney Stone Awareness: A Time Series Analysis from 2004-2023. Clinics and Practice, 14, 915-927. https://doi.org/10.3390/clinpract14030072
[22]
Geraghty, R.M., Davis, N.F., Tzelves, L., Lombardo, R., Yuan, C., Thomas, K., et al. (2023) Best Practice in Interventional Management of Urolithiasis: An Update from the European Association of Urology Guidelines Panel for Urolithiasis 2022. European Urology Focus, 9, 199-208. https://doi.org/10.1016/j.euf.2022.06.014
[23]
Pace, K.T., Weir, M.J., Tariq, N. and Honey, R.J.D. (2000) Low Success Rate of Repeat Shock Wave Lithotripsy for Ureteral Stones after Failed Initial Treatment. Journal of Urology, 164, 1905-1907. https://doi.org/10.1016/s0022-5347(05)66914-5
[24]
Preminger, G.M., Tiselius, H., Assimos, D.G., Alken, P., Buck, C., Gallucci, M., et al. (2007) 2007 Guideline for the Management of Ureteral Calculi. Journal of Urology, 178, 2418-2434. https://doi.org/10.1016/j.juro.2007.09.107
[25]
Demirbas, M., Samli, M., Karalar, M. and Kose, A.C. (2012) Extracorporeal Shockwave Lithotripsy for Ureteral Stones: Twelve Years of Experience with 2836 Patients at a Single Center. Urology Journal, 9, 557-561.
[26]
Martov, A.G. and D.V., E. (2020) Modern Treatment of Urinary Stone Disease: Results Improvement in the Spotlight. Experimental and Clinical Urology, 12, 65-70. https://doi.org/10.29188/2222-8543-2020-12-3-65-70
[27]
Kristyantoro, B., Alif, S., Djojodimedjo, T. and Budiono, B. (2012) The Effectiveness of Renalof® Compared to Kalkurenal® and Placebo. Indonesian Journal of Urology, 19, 73-78.
[28]
Atiés Sánchez, M.C., Edighill Villanueva, V. and Abreu Vázquez, R. (2012) Estudio randomizado a doble ciegas con Renalof® en pacientes portadores de litiasis renal de oxalato de calcio. Revista Cubana de Investigaciones Biomédicas, 31, 87-100. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002012000100010.
[29]
Pereira-Arias, J.G., Gamarra-Quintanilla, M., Urdaneta-Salegui, L.F., Mora-Christian, J.A., Sánchez-Vazquez, A., Astobieta-Odriozola, A. and Ibarluzea-González, G. (2017) Estado actual de la litotricia extracorpórea por ondas de choque en la litiasis urinaria. Archivos Españoles de Urología, 70, 263-287.
[30]
Reynolds, L.F., Kroczak, T. and Pace, K.T. (2018) Indications and Contraindications for Shock Wave Lithotripsy and How to Improve Outcomes. Asian Journal of Urology, 5, 256-263. https://doi.org/10.1016/j.ajur.2018.08.006
[31]
D’Addessi, A., Vittori, M., Racioppi, M., Pinto, F., Sacco, E. and Bassi, P. (2012) Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them—A Review. The Scientific World Journal, 2012, 1-6. https://doi.org/10.1100/2012/619820
[32]
Kamadjou, C., Ambomatei, C., Mbassi, A., Kameni, A., Kolela, D.B. and Angwafor, F. (2021) Evaluation of Extracorporeal Shockwave Lithotripsy in the Management of Renal and Ureteral Calculi. Open Journal of Urology, 11, 474-485. https://doi.org/10.4236/oju.2021.1112048
[33]
Geraghty, R.M., Cook, P., Walker, V. and Somani, B.K. (2020) Evaluation of the Economic Burden of Kidney Stone Disease in the UK: A Retrospective Cohort Study with a Mean Follow-Up of 19 Years. BJU International, 125, 586-594. https://doi.org/10.1111/bju.14991
[34]
Alchimbayev, M.K., Malikh, M.A. and Kuanshaliyev, Z.Y. (2012) Report of Clinical Trial. Results of Renal of® in Urolithiasis Patients. Bulletin of Surgery of Kazakhstan, 1, 81-82.
